FR2882763B1 - Procede pour le pronostic d'une reponse a un traitement - Google Patents

Procede pour le pronostic d'une reponse a un traitement

Info

Publication number
FR2882763B1
FR2882763B1 FR0550540A FR0550540A FR2882763B1 FR 2882763 B1 FR2882763 B1 FR 2882763B1 FR 0550540 A FR0550540 A FR 0550540A FR 0550540 A FR0550540 A FR 0550540A FR 2882763 B1 FR2882763 B1 FR 2882763B1
Authority
FR
France
Prior art keywords
prognosis
response
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0550540A
Other languages
English (en)
Other versions
FR2882763A1 (fr
Inventor
Myew Ling Toh
Pierre Miossec
Jean Luc Blond
Bruno Mougin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomerieux SA
Hospices Civils de Lyon HCL
Original Assignee
Biomerieux SA
Hospices Civils de Lyon HCL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomerieux SA, Hospices Civils de Lyon HCL filed Critical Biomerieux SA
Priority to FR0550540A priority Critical patent/FR2882763B1/fr
Priority to US11/883,527 priority patent/US20100267014A1/en
Priority to PCT/FR2006/050175 priority patent/WO2006092530A1/fr
Priority to JP2007557554A priority patent/JP2008531033A/ja
Priority to EP06726199A priority patent/EP1853728A1/fr
Publication of FR2882763A1 publication Critical patent/FR2882763A1/fr
Application granted granted Critical
Publication of FR2882763B1 publication Critical patent/FR2882763B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
FR0550540A 2005-03-01 2005-03-01 Procede pour le pronostic d'une reponse a un traitement Expired - Fee Related FR2882763B1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR0550540A FR2882763B1 (fr) 2005-03-01 2005-03-01 Procede pour le pronostic d'une reponse a un traitement
US11/883,527 US20100267014A1 (en) 2005-03-01 2006-02-28 Method for Prognosis of a Response to a Treatment
PCT/FR2006/050175 WO2006092530A1 (fr) 2005-03-01 2006-02-28 Procede pour le pronostic d ' une reponse a un traitement par l ' infliximab des patients atteints de polyarthrite rhumatoide
JP2007557554A JP2008531033A (ja) 2005-03-01 2006-02-28 処置に対する応答の予後診断のための方法
EP06726199A EP1853728A1 (fr) 2005-03-01 2006-02-28 Procede pour le pronostic d'une reponse a un traitement par l' infliximab des patients atteints de polyarthrite rhumatoide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0550540A FR2882763B1 (fr) 2005-03-01 2005-03-01 Procede pour le pronostic d'une reponse a un traitement

Publications (2)

Publication Number Publication Date
FR2882763A1 FR2882763A1 (fr) 2006-09-08
FR2882763B1 true FR2882763B1 (fr) 2007-05-18

Family

ID=35045189

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0550540A Expired - Fee Related FR2882763B1 (fr) 2005-03-01 2005-03-01 Procede pour le pronostic d'une reponse a un traitement

Country Status (5)

Country Link
US (1) US20100267014A1 (fr)
EP (1) EP1853728A1 (fr)
JP (1) JP2008531033A (fr)
FR (1) FR2882763B1 (fr)
WO (1) WO2006092530A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2679995A1 (fr) * 2007-05-31 2014-01-01 AbbVie Inc. Biomarqueurs prédictifs de la réactivité aux inhibiteurs TNF-alfa dans des troubles auto-immuns
EP2056110A1 (fr) * 2007-10-31 2009-05-06 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Biomarqueur pour prédire une réponse à un traitement par un anti-TNF-alpha
WO2010038840A1 (fr) * 2008-10-03 2010-04-08 Tsuzaka Kensei PROCÉDÉ DE PRÉDICTION DE L'EFFICACITÉ PHARMACOLOGIQUE D'UNE PRÉPARATION D'ANTICORPS ANTI-TNFα SUR LA POLYARTHRITE RHUMATOÏDE, ET APPAREIL DE PRÉDICTION DE L'EFFICACITÉ PHARMACOLOGIQUE
HUP1600456A2 (en) 2016-07-19 2018-01-29 Richter Gedeon Nyrt Novel cell-based tnf-alpha binding assay
RU2753793C1 (ru) * 2020-10-24 2021-08-23 Федеральное государственное бюджетное научное учреждение «Научно-исследовательский институт ревматологии имени В.А. Насоновой» (ФГБНУ НИИР им. В.А. Насоновой) Способ прогнозирования эффективности терапии метотрексатом больных ревматоидным артритом

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100603683B1 (ko) * 2000-12-22 2006-07-20 가부시키가이샤 로코모젠 활막세포 단백질

Also Published As

Publication number Publication date
FR2882763A1 (fr) 2006-09-08
JP2008531033A (ja) 2008-08-14
WO2006092530A1 (fr) 2006-09-08
US20100267014A1 (en) 2010-10-21
EP1853728A1 (fr) 2007-11-14

Similar Documents

Publication Publication Date Title
FR19C1005I2 (fr) Nano-corps ameliores (tm) pour le traitement des troubles lies a l'agregation
FR2902418B1 (fr) Procede et installation pour le traitement des eaux integrant un traitement biologique a bacteries fixees et une floculation-decantation
FR2881732B1 (fr) Procede pour la purification de chlorure d'hydrogene
FR13C0029I2 (fr) Compositions pour le traitement de troubles gastro-intestinaux
FR2907933B1 (fr) Procede pour la creation d'une description des exigences pour un systeme incorpore.
FR2915201B1 (fr) Procede pour la preparation d'anhydrides polyalcenylsucciniques
FR2881846B1 (fr) Procede de definition d'une face supplementaire pour lunettes
FR2909205B1 (fr) Procede de designation d'un objet dans une image.
FR2882763B1 (fr) Procede pour le pronostic d'une reponse a un traitement
FR2896422B1 (fr) Systeme de drainage pour le traitement de l'hydrocephalie
FR2894247B1 (fr) Procede pour l'epuration d'une solution aqueuse chargee en iodure, calcium, magnesium
FR2895406B1 (fr) Procede pour la fabrication de 2,3-dimethylbut-1-ene
FR2904236B1 (fr) Installation de traitement d'une eau
FR2903018B1 (fr) Procede cosmetique pour limiter le creusement du visage du a l'age
FR2865403B1 (fr) Composition pour le traitement d'une pathologie associee a la msrv/herv-w
FR2869030B1 (fr) Procede de production d'alpha-alumine particulaire
FR2919310B1 (fr) Procede pour le traitement anticorrosion d'une unite industrielle
FR2905600B1 (fr) Traitement des vertiges par l'acetyl-l-leucine.
FR2894596B1 (fr) Procede d'autocalibration de biopuces
FR2889855B1 (fr) Procede de renovation des installations de comptage d'eau.
FR2848223B1 (fr) Nouveau procede d'isolement des endotoxines.
FR2886946B1 (fr) Procede pour le diagnoctic/pronostic du cancer du sein
FR2873608B1 (fr) Procede pour renforcer localement une structure metallique mince
FR2886867B1 (fr) Procede de fabrication d'un compose de type gel, pour le traitement d'effluent
FR2880186B1 (fr) Procede de traitement d'une surface de plaquette

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20091130